308 related articles for article (PubMed ID: 29441713)
1. Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.
Zhao C; Isenberg JS; Popel AS
J Cell Mol Med; 2018 Apr; 22(4):2086-2097. PubMed ID: 29441713
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia.
Kwak C; Jin RJ; Lee C; Park MS; Lee SE
BJU Int; 2002 Feb; 89(3):303-9. PubMed ID: 11856116
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.
Miyata Y; Sakai H
Int J Mol Sci; 2013 Jun; 14(6):12249-72. PubMed ID: 23749112
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer.
Tokunaga T; Nakamura M; Oshika Y; Abe Y; Ozeki Y; Fukushima Y; Hatanaka H; Sadahiro S; Kijima H; Tsuchida T; Yamazaki H; Tamaoki N; Ueyama Y
Br J Cancer; 1999 Jan; 79(2):354-9. PubMed ID: 9888480
[TBL] [Abstract][Full Text] [Related]
5. Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts.
Zhao XM; Hu Y; Miller GG; Mitchell RN; Libby P
Circulation; 2001 Jan; 103(4):525-31. PubMed ID: 11157717
[TBL] [Abstract][Full Text] [Related]
6. The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer.
Reiher FK; Ivanovich M; Huang H; Smith ND; Bouck NP; Campbell SC
J Urol; 2001 Jun; 165(6 Pt 1):2075-81. PubMed ID: 11371931
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional and Post-Transcriptional Regulation of Thrombospondin-1 Expression: A Computational Model.
Zhao C; Isenberg JS; Popel AS
PLoS Comput Biol; 2017 Jan; 13(1):e1005272. PubMed ID: 28045898
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality.
Baltaci S; Orhan D; Göğüş C; Filiz E; Tulunay O; Göğüş O
Eur Urol; 2003 Jul; 44(1):76-81; discussion 81. PubMed ID: 12814678
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor.
Laderoute KR; Alarcon RM; Brody MD; Calaoagan JM; Chen EY; Knapp AM; Yun Z; Denko NC; Giaccia AJ
Clin Cancer Res; 2000 Jul; 6(7):2941-50. PubMed ID: 10914744
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.
Lawler J
J Cell Mol Med; 2002; 6(1):1-12. PubMed ID: 12003665
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.
Smadja DM; d'Audigier C; Bièche I; Evrard S; Mauge L; Dias JV; Labreuche J; Laurendeau I; Marsac B; Dizier B; Wagner-Ballon O; Boisson-Vidal C; Morandi V; Duong-Van-Huyen JP; Bruneval P; Dignat-George F; Emmerich J; Gaussem P
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):551-9. PubMed ID: 21148423
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma.
Kawahara N; Ono M; Taguchi K; Okamoto M; Shimada M; Takenaka K; Hayashi K; Mosher DF; Sugimachi K; Tsuneyoshi M; Kuwano M
Hepatology; 1998 Dec; 28(6):1512-7. PubMed ID: 9828214
[TBL] [Abstract][Full Text] [Related]
15. Exercise and insulin-like growth factor 1 supplementation improve angiogenesis and angiogenic cytokines in a rat model of diabetes-induced neuropathy.
Saboory E; Gholizadeh-Ghaleh Aziz S; Samadi M; Biabanghard A; Chodari L
Exp Physiol; 2020 May; 105(5):783-792. PubMed ID: 32053260
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma.
Maeda K; Nishiguchi Y; Yashiro M; Yamada S; Onoda N; Sawada T; Kang SM; Hirakawa K
Int J Mol Med; 2000 Apr; 5(4):373-8. PubMed ID: 10719053
[TBL] [Abstract][Full Text] [Related]
20. Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production.
Qian X; Rothman VL; Nicosia RF; Tuszynski GP
Pathol Oncol Res; 2001; 7(4):251-9. PubMed ID: 11882904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]